Funding for this research was provided by:
the Deutsche Forschungsgemeinschaft (grant number: SFB1039, projecrt B3), TRIP, EKF
This work was supported by the Deutsche Forschungsgemeinschaft (grant number: SFB1039;project B3).
Translational Research Innovation Pharma graduate school
LOEWE Cell and Gene Therapy Frankfurt faculty
Deutschen Konsortium für Translationale Krebsforschung
the Deutsche Forschungsgemeinschaft
Received: 1 June 2018
Revised: 3 January 2019
Accepted: 5 January 2019
First Online: 28 February 2019
Compliance with ethical standards
: The authors declare that they have no conflict of interest.